Physician profile
Mark C Downey
NPI 1003850744
$330.29
in general payments reported to CMS, 2019-2025
10 companies · $25.34 in 2025
The $25.34 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.18 · 2021: $17.25 · 2022: $54.38 · 2023: $77.37 · 2024: $57.77 · 2025: $25.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $160.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $62.88 | 2022-2023 | Azstarys |
| Sanofi Pasteur INC. | $57.37 | 2019-2023 | |
| Pfizer INC. | $53.63 | 2019-2024 | |
| Shire North American Group INC | $37.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.67 | 2022-2024 | Flumist Quadrivalent |
| Alk-Abello, INC | $25.34 | 2025 | Neffy |
| Glaxosmithkline, LLC. | $18.40 | 2024 | Bexsero |
| Supernus Pharmaceuticals, INC. | $17.25 | 2021 | |
| Phadia US INC. | $16.44 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Downey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.